Literature DB >> 16452383

Screening examination of premature infants for retinopathy of prematurity.

.   

Abstract

This statement revises a previous statement on screening of preterm infants for retinopathy of prematurity (ROP) that was published in 2001. ROP is a pathologic process that occurs only in immature retinal tissue and can progress to a tractional retinal detachment, which can result in functional or complete blindness. Recent development of peripheral retinal ablative therapy using laser photocoagulation has resulted in the possibility of markedly decreasing the incidence of this poor visual outcome, but the sequential nature of ROP creates a requirement that at-risk preterm infants be examined at proper times to detect the changes of ROP before they become permanently destructive. This statement presents the attributes on which an effective program for detecting and treating ROP could be based, including the timing of initial examination and subsequent reexamination intervals.

Entities:  

Mesh:

Year:  2006        PMID: 16452383     DOI: 10.1542/peds.2005-2749

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  130 in total

Review 1.  Laser treatment for retinopathy of prematurity.

Authors:  Samuel K Houston; Charles C Wykoff; Audina M Berrocal; Ditte J Hess; Timothy G Murray
Journal:  Lasers Med Sci       Date:  2011-12-02       Impact factor: 3.161

2.  Detection of clinically significant retinopathy of prematurity using wide-angle digital retinal photography: a report by the American Academy of Ophthalmology.

Authors:  Michael F Chiang; Michele Melia; Angela N Buffenn; Scott R Lambert; Franco M Recchia; Jennifer L Simpson; Michael B Yang
Journal:  Ophthalmology       Date:  2012-04-27       Impact factor: 12.079

3.  Retinopathy of Prematurity in a rural Neonatal Intensive Care Unit in South India--a prospective study.

Authors:  Bhavana Hungi; Anand Vinekar; Narendra Datti; Pushpalatha Kariyappa; Sherine Braganza; Susheela Chinnaiah; Krishnamurthy Donthi; Bhujang Shetty
Journal:  Indian J Pediatr       Date:  2012-02-23       Impact factor: 1.967

4.  Plus disease in retinopathy of prematurity: quantitative analysis of vascular change.

Authors:  Preeti J Thyparampil; Yangseon Park; M E Martinez-Perez; Thomas C Lee; David J Weissgold; Audina M Berrocal; R V Paul Chan; John T Flynn; Michael F Chiang
Journal:  Am J Ophthalmol       Date:  2010-10       Impact factor: 5.258

Review 5.  Retinopathy of prematurity.

Authors:  Deepak Chawla; Ramesh Agarwal; Ashok Deorari; Vinod K Paul; Parijat Chandra; Rajvardhan V Azad
Journal:  Indian J Pediatr       Date:  2010-10-27       Impact factor: 1.967

6.  Changing spectrum of retinopathy of prematurity (ROP) and variations among siblings of multiple gestation.

Authors:  Vikrant Sood; Harish Chellani; Sugandha Arya; B P Guliani
Journal:  Indian J Pediatr       Date:  2011-10-15       Impact factor: 1.967

7.  Neonatologists' practices and experiences in arranging retinopathy of prematurity screening services.

Authors:  Alex R Kemper; David K Wallace
Journal:  Pediatrics       Date:  2007-09       Impact factor: 7.124

8.  Importance of birth weight as a risk factor for severe retinopathy of prematurity when gestational age is 30 or more weeks.

Authors:  Leslie M Pierce; Edward L Raab; Ian R Holzman; Robin N Ginsburg; Scott E Brodie; Annemarie Stroustrup
Journal:  Am J Ophthalmol       Date:  2014-02-26       Impact factor: 5.258

9.  Parental perceptions toward digital imaging and telemedicine for retinopathy of prematurity management.

Authors:  Joo-Yeon Lee; Yunling E Du; Osode Coki; John T Flynn; Justin Starren; Michael F Chiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-09-23       Impact factor: 3.117

10.  Telemedical diagnosis of retinopathy of prematurity: accuracy of expert versus non-expert graders.

Authors:  Steven L Williams; Lu Wang; Steven A Kane; Thomas C Lee; David J Weissgold; Audina M Berrocal; Daniel Rabinowitz; Justin Starren; John T Flynn; Michael F Chiang
Journal:  Br J Ophthalmol       Date:  2009-12-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.